Riskpilot← Back to searchSign inGet full accessPulselavage AB
ABActiveOrg 5566800933Rubanksgatan 8Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20051 employees
Revenue 2025
SEK 14,2M
+16% vs 2024
EBITDA margin
-10.8%
-157% vs 2024
Equity ratio
54.0%
Financial strength
Net profit 2025
SEK -10K
-155% vs 2024
| Revenue | SEK 14,2M | +16% |
| EBITDA | SEK -1,5M | -157% |
| Net profit | SEK -10K | -155% |
| Total assets | SEK 11,7M | +14% |
| Equity | SEK 6,3M | +0% |
| Employees | 1 | — |
Legal name
Pulselavage AB
Org number
5566800933
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3 maj 2005
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att förvalta fast och lös egendom, bedriva konsultverksamhet inom medicin och sjukvård, bedriva import och försäljning av varor till sjukvård och därmed förenlig verksamhet.
Address
Rubanksgatan 8
Email
promeduc@promeduc.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 8 859 | 11 866 | 10 106 | 12 199 | 14 154 |
| Staff expenses | — | −936 | — | −1 632 | −1 687 |
| EBITDA | 62 | 2 861 | −5 313 | −597 | −1 534 |
| Depreciation & amort. | −70 | −70 | −10 | −10 | −10 |
| EBIT | −8 | 2 791 | −5 323 | −608 | −1 545 |
| Net financials | — | 70 | 31 | 32 | 35 |
| Profit before tax | −8 | 2 861 | 7 208 | 24 | −9 |
| Tax | −0 | −579 | −1 483 | −6 | −0 |
| Net profit | −8 | 2 283 | 5 725 | 18 | −10 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 13 201 | 15 457 | 10 684 | 10 214 | 11 688 |
| Equity | 1 095 | 2 578 | 6 303 | 6 320 | 6 310 |
| Long-term debt | 0 | — | 0 | — | — |
| Short-term debt | 12 106 | 12 879 | 4 381 | 3 894 | 5 378 |
| Total debt | 12 106 | 12 879 | 4 381 | 3 894 | 5 378 |
EBITDA margin
-10.8%
This company
15.8%
Market median
-168% vs market
20212025
Equity ratio
54.0%
This company
38.2%
Market median
+41% vs market
20212025
Return on equity
-0.2%
This company
18.4%
Market median
-101% vs market
20212025
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
20212025
Asset turnover
1.21×
This company
1.12×
Market median
+8% vs market
20212025
Debt / equity
0.85×
This company
0.62×
Market median
+37% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MM | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ecin Consult AB
Pulselavage AB Board members of Pulselavage AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magnus Mats Johan Hedin | Audit | 0 companies |
| Pontus Sven Henrik Forsberg | Deputy Board Member | 0 companies |
| Urban Carl Fredrik Forsberg | Board of Directors | 0 companies |